Actively Recruiting
Restorative Effects of Sleep on Everyday Health and Wellbeing: A Treatment Study
Led by University of Notre Dame · Updated on 2026-04-23
115
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the mechanisms through which Cognitive Behavioral Therapy for Insomnia (CBT-I) leads to improvements in sleep and sleep-related daytime outcomes, specifically as it relates to cortisol and the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary stress response system. The primary research aims are: 1) To determine whether changes in cortisol functioning are related to improvements in sleep consolidation (4-week CBT-I), sleep duration (10-week CBT-I) or both, AND 2) to examine whether these improvements are more pronounced among individuals with insomnia and short sleep duration (compared to insomnia with 'normal' sleep duration).This study will recruit individuals with chronic insomnia: half with reported short sleep duration (less than 6 hours of sleep on an average night) and half with reported non-short sleep duration (6 or more hours per night). Participants will complete an in-lab assessment on four different occasions. During the first visit, they will confirm eligibility, complete an online survey, complete an in-lab stress task (with saliva samples), and provide a hair sample to measure cortisol (a hormone). They will then be sent home with a home sleep test as a final eligibility check (to rule out sleep disorders other than insomnia), an actigraphy watch to measure their sleep, and collection tubes to provide saliva samples to measure cortisol. We will then track the participants' sleep using online daily diaries and actigraphy for four week. Following the 4-week baseline period, participants will come in for a second in-lab visit (same procedures as the first visit) and then be randomized to receive either four or ten weeks of Cognitive Behavioral Therapy for Insomnia (CBT-I). CBT-I is a empirically supported behavioral treatment for insomnia and the first-line treatment for chronic insomnia. Sleep patterns and insomnia symptoms will continue to be monitored via diaries during the intervention phase. The third visit will take place once the participant has completed the intervention and the fourth visit will occur three months following the third visit (3 months post-treatment). The 3rd and 4th visits will again replicate the same procedures conducted during the initial lab visit.
CONDITIONS
Official Title
Restorative Effects of Sleep on Everyday Health and Wellbeing: A Treatment Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18-years-old
- Speaks English
- Meets DSM-5 criteria for Insomnia Disorder, confirmed by interview
You will not qualify if you...
- Sleep disorders other than Insomnia
- Endocrine disorders
- Extreme sleep schedule such as shift work
- Currently taking sleep medication
- Currently taking medication for endocrine dysfunction
- Currently taking medication that affects sleep or cortisol levels
- Excessive alcohol or substance use or alcohol/substance use disorder
- Serious mental illness
- Chronic medical conditions that may worsen with sleep restriction
- Pregnant or nursing women
- Women in the peri-menopausal stage due to hormonal fluctuations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Notre Dame
Notre Dame, Indiana, United States, 46556
Actively Recruiting
Research Team
I
Ivan Vargas
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here